Simplified implantation of single-lead pectoral cardioverter defibrillators using device-based testing.
Device-based testing of single-lead pectoral defibrillators (defibrillation efficacy testing without an external defibrillation system after complete implantation of the device) resulted in an adequate defibrillation threshold (< or = 20 J) in 45 of 50 study patients (90%). Mean surgical implantation time (skin to skin) was 62 +/- 29 minutes without perioperative mortality and without implantable cardioverter defibrillator infection during follow-up. Thus, device-based testing appears to be a simple and safe method to test defibrillation efficacy of single-lead pectoral defibrillators.
Grimm
W
W
Department of Cardiology, Hospital of the Philipps-University of Marburg, Germany.
Timmann
U
U
Menz
V
V
Hoffmann
J
J
Funck
R
R
Moosdorf
R
R
Maisch
B
B
D000293:Adolescent; D000328:Adult; D000368:Aged; D017147:Defibrillators, Implantable; D004867:Equipment Design; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008422:Materials Testing / Q000379:methods*; D008875:Middle Aged; D012449:Safety; D019616:Thoracic Surgical Procedures / Q000379:methods; D016896:Treatment Outcome